Clinical trial

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

NCT01352429

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2009-08-01

PhaseN/A

Study timeline

Study start (unknown)2009-08-01Date precision: month

Registry last updated2026-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Adenocarcinomaunresolved

Interventions

Proton TherapyRADIATION

IMRTRADIATION

Sponsors & collaborators

Abramson Cancer Center at Penn Medicinelead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1 BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01352429 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.